These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 38022534)
1. Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches. Hazrati A; Malekpour K; Mirsanei Z; Khosrojerdi A; Rahmani-Kukia N; Heidari N; Abbasi A; Soudi S Front Immunol; 2023; 14():1280601. PubMed ID: 38022534 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276 [TBL] [Abstract][Full Text] [Related]
3. The Multifunction Role of Tumor-Associated Mesenchymal Stem Cells and Their Interaction with Immune Cells in Breast Cancer. Chauhan A; Agarwal S; Masih M; Gautam PK Immunol Invest; 2023 Nov; 52(7):856-878. PubMed ID: 37615117 [TBL] [Abstract][Full Text] [Related]
4. NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions. Ghosh T; Nandi P; Ganguly N; Guha I; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Baral R; Bose A Stem Cell Res Ther; 2019 Sep; 10(1):296. PubMed ID: 31547863 [TBL] [Abstract][Full Text] [Related]
5. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment. Frisbie L; Buckanovich RJ; Coffman L Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cells in the Tumor Microenvironment. Atiya H; Frisbie L; Pressimone C; Coffman L Adv Exp Med Biol; 2020; 1234():31-42. PubMed ID: 32040853 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment. François S; Usunier B; Forgue-Lafitte ME; L'Homme B; Benderitter M; Douay L; Gorin NC; Larsen AK; Chapel A Stem Cells Transl Med; 2019 Mar; 8(3):285-300. PubMed ID: 30451398 [TBL] [Abstract][Full Text] [Related]
9. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells. Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity. Harrell CR; Volarevic A; Djonov VG; Jovicic N; Volarevic V Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830312 [TBL] [Abstract][Full Text] [Related]
11. Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors. Le Naour A; Prat M; Thibault B; Mével R; Lemaitre L; Leray H; Joubert MV; Coulson K; Golzio M; Lefevre L; Mery E; Martinez A; Ferron G; Delord JP; Coste A; Couderc B J Mol Cell Biol; 2020 Apr; 12(3):202-215. PubMed ID: 31504643 [TBL] [Abstract][Full Text] [Related]
12. Similarities between Tumour Immune Response and Chronic Wound Microenvironment: Influence of Mesenchymal Stromal/Stem Cells. Peta KT; Ambele MA; Pepper MS J Immunol Res; 2021; 2021():6649314. PubMed ID: 33860061 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells induce PD-L1 expression through the secretion of CCL5 in breast cancer cells. Aboulkheyr Es H; Bigdeli B; Zhand S; Aref AR; Thiery JP; Warkiani ME J Cell Physiol; 2021 May; 236(5):3918-3928. PubMed ID: 33145762 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines. Liang W; Chen X; Zhang S; Fang J; Chen M; Xu Y; Chen X Cell Mol Biol Lett; 2021 Jan; 26(1):3. PubMed ID: 33472580 [TBL] [Abstract][Full Text] [Related]
15. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity. Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843 [TBL] [Abstract][Full Text] [Related]
16. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Whiteside TL Semin Immunol; 2018 Feb; 35():69-79. PubMed ID: 29289420 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem/Stromal cells in solid tumor Microenvironment: Orchestrating NK cell remodeling and therapeutic insights. Zhang H; Cao X; Gui R; Li Y; Zhao X; Mei J; Zhou B; Wang M Int Immunopharmacol; 2024 Dec; 142(Pt B):113181. PubMed ID: 39305890 [TBL] [Abstract][Full Text] [Related]
18. Glioblastoma-Associated Mesenchymal Stem/Stromal Cells and Cancer-Associated Fibroblasts: Partners in Crime? Lootens T; Roman BI; Stevens CV; De Wever O; Raedt R Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396962 [TBL] [Abstract][Full Text] [Related]
19. How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive. Poggi A; Varesano S; Zocchi MR Front Immunol; 2018; 9():262. PubMed ID: 29515580 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment. Razmkhah M; Abtahi S; Ghaderi A Curr Stem Cell Res Ther; 2019; 14(1):43-51. PubMed ID: 30112998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]